KHN Morning Briefing

Summaries of health policy coverage from major news organizations.

Hip Implant Safety At Issue In High-Stakes Trial

Los Angeles Times: J&J Gambled On Hip Implant Safety, Lawyer Alleges
Healthcare giant Johnson & Johnson played "Russian roulette" with patient safety by ignoring high failure rates and surgeons' complaints about its once-popular artificial hip, a Los Angeles jury was told during closing arguments at a high-stakes medical trial for the company. Jurors heard arguments from both sides Thursday in a case that pits the world's biggest seller of medical products against Loren Kransky, a 65-year-old former prison guard in Montana who claims he suffered metal poisoning and other health problems from the company's ASR XL hip implant he received in 2007 (Terhune, 2/28).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.